Abstract:Lei Lei, Ke Wang Henan Provincial Chest Hospital, Zhengzhou, 450008, Henan, People's Republic of China Correspondence: Ke Wang, Email Background: Preserving nephrons while avoiding tumor recurrence during the treatment of renal cell carcinoma remains as a challenge in clinic. To achieve desired therapeutic outcome, we developed specific nanozymes based on the tumor microenvironment and evaluated its efficacy in combination with radiotherapy. Methods: Herein, a hybrid nanozyme CeO 2 @Au-PEG nanocomposite nanoparticle (NPs) was developed for the treatment of renal tumor. It was composed of gold nanozyme decorated CeO 2 nanorods and exhibited both glucose-oxidase like by gold nanozyme and peroxidase-like catalytic activities. Due to the high metabolic rate of tumor cells, they take up a huge amount of glucose to survive and proliferate. Therefore, we generated CeO 2 @Au-PEG NPs, which exhausted glucose in the tumor tissue and generated hydrogen peroxide, depleting the source of energy and causing tumor cell death. Then the generated hydrogen peroxide was degraded by the peroxidase-mimicking properties of CeO 2 @Au-PEG NPs, elevating oxidative stress and thus enhancing tumor cell death. Moreover, due to the high mass nuclei of gold and cerium, they could further sensitize the tumors to radiotherapy and thus thoroughly eliminate tumors. Results: With enough biocompatibility, CeO 2 @Au-PEG NPs showed superior ability to deplete glucose as well as enhance oxidative stress by producing reactive oxygen species in RENCA cells under ionizing irradiation. Moreover, CeO 2 @Au-PEG NPs greatly improved radiotherapy mediated tumor ablation in tumor bearing mice. Conclusion: Systematic experiments demonstrated the synergistic therapeutic effects of the combination of CeO 2 @Au-PEG NPs and radiotherapy in renal tumor model, which may serve as a promising strategy for treating renal cancer patients in the clinic. Keywords: nanozyme, radiotherapy, glucose consumption, reactive oxygen species, renal cell carcinoma According to the cancer statistics estimated in 2023, the incidence rate of tumors in the urinary system ranked among the top ten cancers. 1 Among all the estimated cases of urinary cancer, cancers occurring in the kidney and renal pelvis account for one-third of new diagnoses with renal cell carcinoma accounting for 90% of the cases with kidney cancer. 2 Surgery including partial nephrectomy as well as radical nephrectomy is widely performed during the treatment of renal cell carcinoma patients. 3,4 Targeted therapies utilizing chemotherapeutic drugs and immunotherapy are being utilized as strategies for systemic therapy. 5 However, it is necessary to preserve as much nephron as possible during the treatment of renal cell carcinoma since the kidney plays an important role in the excretion of waste from the body. Meanwhile, incomplete clearance of cancer cells might lead to tumor recurrence. 6,7 Therefore, to improve the patient's quality of life as well as inhibit tumor recurrence, researchers are exploring nanocomposites, which can specifically respond to the tumor microenvironment (TME) or can be tailored according to the tumor characteristics. 8–10 The introduction of nanocomposite promotes tumor ablation without impairing kidney function, suggesting its promising potential for treating renal cell carcinoma patients. Compared to normal tissues, tumor tissues with high metabolism tend to consume more glucose. Due to this, glucose oxidase (GOx) which catalyzes the conversion of glucose and oxygen to gluconolactone and hydrogen peroxide has gained increasing attention in the nanomedicine field. 11–14 The energy depletion caused by these enzymes, and the release of hydrogen peroxide (H 2 O 2 ) cause tumor cell death. In a recent study, tri-metal nanospheres decorated with glucose oxidase termed AuPtAg-GOx were engineered for synergistic tumor therapy via starvation therapy and photothermal therapy to augment immunotherapy efficacy. Under laser irradiation, the glucose depletion efficiency of AuPtAg-GOx was augmented, which enhanced the therapeutic outcome. 15 Zhang et al reported a MnSiO 3 @Met@GOx nanocomposite that could be triggered in mild-acidic pH and GSH overexpressing TME. H 2 O 2 derived from glucose in the presence of the nanocomposite was converted to toxic hydroxyl radicals (OH) by decomposed Mn 2+ , leading to cell death and tumor ablation. 16 To effectively inhibit glioma tumor recurrence after surgery, Li et al developed a sprayed gel containing GOx@MnCaP nanoparticles (NPs), which improved the therapeutic outco -Abstract Truncated-

Radiofrequency Induced UCST-type Gel-Sol Transition of Metformin-Conjugated Nanogels for Precisely Synergizing Thermal Ablation and Blood-Vessel Embolization

Metformin-Induced Stromal Depletion to Enhance the Penetration of Gemcitabine-Loaded Magnetic Nanoparticles for Pancreatic Cancer Targeted Therapy

The influence of solid-state molecular organization on the reaction paths of thiyl radicals.

Erythrocyte Membrane-Camouflaged PCN-224 Nanocarriers Integrated with Platinum Nanoparticles and Glucose Oxidase for Enhanced Tumor Sonodynamic Therapy and Synergistic Starvation Therapy.

Science to Practice: Enhancing Photothermal Ablation of Colorectal Liver Metastases with Targeted Hybrid Nanoparticles

[A cancer family].

Metformin-Mediated Fast Charge-Reversal Nanohybrid for Deep Penetration Piezocatalysis-Augmented Chemodynamic Immunotherapy of Cancer

Systemic siRNA Nanoparticle-Based Drugs Combined with Radiofrequency Ablation for Cancer Therapy

Biodegradable Microembolics with Nanografted Polyanions Enable High-Efficiency Drug Loading and Sustained Deep-Tumor Drug Penetration for Locoregional Chemoembolization Treatment

Diastereoselective synthesis of (+/-)-(3-aminocyclopentane)alkylphosphinic acids, conformationally restricted analogues of GABA.

Smart-Polypeptide-Coated Mesoporous Fe 3 O 4 Nanoparticles: Non-Interventional Target-Embolization/Thermal Ablation and Multimodal Imaging Combination Theranostics for Solid Tumors

Artificial “Nano-Targeted Cells” for Bimodal Imaging-Guided Tumor Cocktail Therapy

Synergistic Combination of an Intelligent Nanozyme and Radiotherapy for Treating Renal Cancer

Targeting SUMOylation with an injectable nanocomposite hydrogel to optimize radiofrequency ablation therapy for hepatocellular carcinoma

Synergic fabrication of multifunctional liposomes nanocomposites for improved radiofrequency ablation combination for liver metastasis cancer therapy

Platelet-mimicking nanoparticles co-loaded with W18O49 and metformin alleviate tumor hypoxia for enhanced photodynamic therapy and photothermal therapy.

Enhancing Radiofrequency Ablation for Hepatocellular Carcinoma: Nano‐Epidrug Effects on Immune Modulation and Antigenicity Restoration

Dual Functional LipoMET Mediates Envelope-type Nanoparticles to Combinational Oncogene Silencing and Tumor Growth Inhibition

Tailoring Chemoimmunostimulant Bioscaffolds for Inhibiting Tumor Growth and Metastasis after Incomplete Microwave Ablation

Tumor-killing nanoreactors fueled by tumor debris can enhance radiofrequency ablation therapy and boost antitumor immune responses

Homogenous multifunctional microspheres induce ferroptosis to promote the anti-hepatocarcinoma effect of chemoembolization